Additionally, hypermethylation of Wnt antagonists/inhibitors including RUNX-3, DKK-3 (Dickkopf-3), and SFRP1 (Secreted Frizzled Related Protein 1) is associated with an elevated chance of ESCC recurrence. Here, SFRP1 is linked to esophageal squamous cell carcinoma.